Information card for entry 4510487
| Common name |
Blonanserin-suberic acid cocrystal |
| Chemical name |
(2-(4-ethyl-l-piperazinyl)-4-(4-fluorophenyl)-5, 6, 7, 8, 9, 10-hexahydrocycloocta[ b]-pyridine)-1,8-Octanedioic acid |
| Formula |
C27 H37 F N3 O2 |
| Calculated formula |
C27 H37 F N3 O2 |
| Title of publication |
High Solubility Crystalline Pharmaceutical Forms of Blonanserin |
| Authors of publication |
Maddileti, D.; Swapna, Battini; Nangia, Ashwini |
| Journal of publication |
Crystal Growth & Design |
| Year of publication |
2014 |
| Journal volume |
14 |
| Journal issue |
5 |
| Pages of publication |
2557 |
| a |
13.655 ± 0.012 Å |
| b |
11.54 ± 0.01 Å |
| c |
15.669 ± 0.014 Å |
| α |
90° |
| β |
103.515 ± 0.013° |
| γ |
90° |
| Cell volume |
2401 ± 4 Å3 |
| Cell temperature |
100 ± 2 K |
| Ambient diffraction temperature |
100 ± 2 K |
| Number of distinct elements |
5 |
| Space group number |
14 |
| Hermann-Mauguin space group symbol |
P 1 21/n 1 |
| Hall space group symbol |
-P 2yn |
| Residual factor for all reflections |
0.0634 |
| Residual factor for significantly intense reflections |
0.043 |
| Weighted residual factors for significantly intense reflections |
0.096 |
| Weighted residual factors for all reflections included in the refinement |
0.1028 |
| Goodness-of-fit parameter for all reflections included in the refinement |
0.988 |
| Diffraction radiation wavelength |
0.71073 Å |
| Diffraction radiation type |
MoKα |
| Has coordinates |
Yes |
| Has disorder |
No |
| Has Fobs |
No |
For the version history of this entry, please navigate to main COD server.
The link is:
https://www.crystallography.net/4510487.html